Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,515 | -39,512 | -21,158 | -77,331 | -41,760 |
| Depreciation Amortization | -971 | -966 | -605 | -3,127 | -2,144 |
| Income taxes - deferred | N/A | N/A | N/A | -2,164 | N/A |
| Accounts receivable | N/A | -3,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,897 | 4,553 | -2,013 | 1,200 | 1,210 |
| Other Working Capital | -913 | -6,361 | -4,596 | -9,659 | -5,164 |
| Other Operating Activity | 5,427 | 5,488 | 5,837 | 33,409 | 9,476 |
| Operating Cash Flow | $-53,075 | $-39,798 | $-22,535 | $-57,672 | $-38,382 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,605 | 31,125 | 15,821 | 8,392 | -18,265 |
| PPE Investments | -9 | N/A | N/A | -237 | -237 |
| Investing Cash Flow | $42,596 | $31,125 | $15,821 | $8,155 | $-18,502 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2 | 2 | 2 | 59,566 | 59,516 |
| Other Financing Activity | -77 | -69 | -2 | -240 | -240 |
| Financing Cash Flow | $-75 | $-67 | $0 | $59,326 | $59,276 |
| Beginning Cash Position | 20,945 | 20,945 | 20,945 | 11,136 | 11,136 |
| End Cash Position | 10,391 | 12,205 | 14,231 | 20,945 | 13,528 |
| Net Cash Flow | $-10,554 | $-8,740 | $-6,714 | $9,809 | $2,392 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,075 | -39,798 | -22,535 | -57,672 | -38,382 |
| Capital Expenditure | -9 | N/A | N/A | -237 | -237 |
| Free Cash Flow | -53,084 | -39,798 | -22,535 | -57,909 | -38,619 |